Nanotechnology: meeting the future of Veterinary Parasitology Research

Cruz, Amílcar Arenal; Molento, Marcelo Beltrão

doi:10.1590/s0100-736x2015001000004

Cited by 9 publications

(2 citation statements)

References 9 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A powerful composition for parasitic disease management is the result. Diagnostics and treatment for veterinary parasites are set to undergo a revolution as nanotechnology and veterinary parasitology merge [105,106]. Soon, as a result of recent developments in these fields, veterinary science and nanotechnology are predicted to continue to flourish, innovate, and, ultimately, redefine our approach to treating parasitic infections in companion animals (Figure 3).…”

Section: Nanotechnology and Nanoparticle Applicationsmentioning

confidence: 99%

Challenges and Prospective of Enhancing Hydatid Cyst Chemotherapy by Nanotechnology and the Future of Nanobiosensors for Diagnosis

Sadr,

Lotfalizadeh,

Abbasi

et al. 2023

TropicalMed

View full text Add to dashboard Cite

Hydatid cysts have been widely recognized for decades as a common medical problem that affects millions of people. A revolution in medical treatment may be on the prospect of nanotechnology enhancing chemotherapy against hydatid cysts. An overview of nanotechnology’s impact on chemotherapeutics is presented in the current review. It discusses some of the challenges as well as some of the opportunities. The application of nanotechnology to enhance chemotherapy against hydatid cysts is what this review will explore. Nanotechnology is a critical component of delivering therapeutic agents with greater precision and efficiency and targeting hydatid cysts with better efficacy, and minimizing interference with surrounding tissue. However, there are biodistribution challenges, toxicity, and resistance problems associated with nanotherapeutics. Additionally, nanobiosensors are being investigated to enable the early diagnosis of hydatid cysts. A nanobiosensor can detect hydatid cysts by catching them early, non-invasively, rapidly, and accurately. The sensitivity and specificity of diagnostic tests can be enhanced with nanobiosensors because they take advantage of the unique properties of nanomaterials. By providing more precise and customized treatment options for hydatid cysts, nanotechnology may improve therapeutic options and strategies for diagnosing the disease. In conclusion, treatment with nanotechnology to treat hydatid cysts is potentially effective but presents many obstacles. Furthermore, nanobiosensors are being integrated into diagnostic techniques, as well as helping to diagnose patients earlier and more accurately.

show abstract

Section: Nanotechnology and Nanoparticle Applicationsmentioning

confidence: 99%

Challenges and Prospective of Enhancing Hydatid Cyst Chemotherapy by Nanotechnology and the Future of Nanobiosensors for Diagnosis

Sadr,

Lotfalizadeh,

Abbasi

et al. 2023

TropicalMed

View full text Add to dashboard Cite

show abstract

“…Moreover the effectiveness of phytotherapeutic products can be improved, like the recent treatment of antiparasitic silver nano-particles using Cissus quadrangularis against Hippobosca aculata and Rhipicephalus (Boophilus) microplus [42]. Nano-devices also help veterinarians to suggest a correct health management [43]. In Cuba and Brazil some project are currently running using nanopeptides as a preliminary test against ruminant helminths (Haemonchus contortus and Fasciola hepatica).…”

Section: Neurocysticercosis (Ncc)mentioning

confidence: 99%

Immunodiagnosis Tools for Parasitic Diseases

Deepak¹,

Ld²

2016

J Microb Biochem Technol

View full text Add to dashboard Cite

Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics

Sepúlveda‐Crespo

Reguera

Rojo-Vázquez

et al. 2020

Medicinal Research Reviews

View full text Add to dashboard Cite

Helminthiasis is one of the gravest problems worldwide. There is a growing concern on less available anthelmintics and the emergence of resistance creating a major threat to human and livestock health resources. Novel and broad‐spectrum anthelmintics are urgently needed. The free‐living nematode Caenorhabditis elegans could address this issue through automated high‐throughput technologies for the screening of large chemical libraries. This review discusses the strong advantages and limitations for using C elegans as a screening method for anthelmintic drug discovery. C elegans is the best model available for the validation of novel effective drugs in treating most, if not all, helminth infections, and for the elucidation the mode of action of anthelmintic candidates. This review also focuses on available technologies in the discovery of anthelmintics published over the last 15 years with particular attention to high‐throughput technologies over conventional screens. On the other hand, this review highlights how combinatorial and nanomedicine strategies could prolong the use of anthelmintics and control resistance problems.

show abstract

Nanotechnology: meeting the future of Veterinary Parasitology Research

Cited by 9 publications

References 9 publications

Challenges and Prospective of Enhancing Hydatid Cyst Chemotherapy by Nanotechnology and the Future of Nanobiosensors for Diagnosis

Challenges and Prospective of Enhancing Hydatid Cyst Chemotherapy by Nanotechnology and the Future of Nanobiosensors for Diagnosis

Immunodiagnosis Tools for Parasitic Diseases

Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics

Contact Info

Product

Resources

About